Code: MTA7808 | Publication Date: Aug 2025 |
A rising number of chronic diseases and the growing demand for sterile injectable medications with technological developments in drug delivery systems are driving the market expansion. Increased patient preference for self-administered treatments, the growth of biologics and biosimilars, and better healthcare infrastructure all play a big role in the market growth.
The Parenteral Market is witnessing increased adoption of advanced delivery devices like wearable injectors and needle-free systems to improve patient compliance. Prefilled syringes are becoming more and more popular because they are safe and easy to use. Furthermore, the market is trending toward the incorporation of digital health solutions for the monitoring of drug administration. Growing investments in sterile manufacturing facilities and disposable technologies to reduce the risk of contamination are influencing market dynamics. The need for parenteral formulations is also being driven by biologics and biosimilars.
Emerging developments in the Parenteral Market include the rise of wearable injection devices that enable continuous drug delivery and enhance patient convenience. Smart auto-injectors with sensors for tracking adherence and dosage accuracy are becoming more and more popular among businesses. The development of novel formulations is speeding up in an attempt to improve stability and reduce injection frequency. A greater focus on sustainability is driving innovation in single-use technologies and eco-friendly packaging. Product advancements are being accelerated by strategic partnerships between device manufacturers and pharmaceutical companies.
Below is a comprehensive list of the leading market players driving growth in this sector:
Company Name | Baxter International Inc. |
---|---|
Established Year | 1931 |
Headquarters | Deerfield, USA |
Official Website | Click Here |
Develops IV fluids & injectables, focusing on innovation, safety & high-quality healthcare.
Company Name | Fresenius Kabi AG |
---|---|
Established Year | 1999 |
Headquarters | Bad Homburg, Germany |
Official Website | Click Here |
Produces parenteral nutrition, infusion therapies & injectables with emphasis on affordability & accessibility.
Company Name | B. Braun Melsungen AG |
---|---|
Established Year | 1839 |
Headquarters | Melsungen, Germany |
Official Website | Click Here |
Manufactures parenteral solutions, infusion devices & injectables, prioritizing innovation & patient safety.
Company Name | Grifols, S.A. |
---|---|
Established Year | 1940 |
Headquarters | Barcelona, Spain |
Official Website | Click Here |
Specializes in plasma-derived medicines & parenteral solutions, focusing on quality & biopharma innovation.
Company Name | Hospira, Inc. (Pfizer Company) |
---|---|
Established Year | 2004 |
Headquarters | Lake Forest, USA |
Official Website | Click Here |
Develops injectables, infusion tech & parenteral nutrition, ensuring quality & supply reliability.
Company Name | Terumo Corporation |
---|---|
Established Year | 1921 |
Headquarters | Tokyo, Japan |
Official Website | Click Here |
Provides parenteral delivery systems, infusion devices & consumables, with focus on innovation & reliability.
Company Name | Otsuka Pharmaceutical Co., Ltd. |
---|---|
Established Year | 1964 |
Headquarters | Tokyo, Japan |
Official Website | Click Here |
Produces parenteral nutrition & IV solutions, investing in R&D & quality manufacturing.
Company Name | ICU Medical, Inc. |
---|---|
Established Year | 1984 |
Headquarters | San Clemente, USA |
Official Website | Click Here |
Develops parenteral delivery devices & infusion systems, focusing on safety-driven innovations.
Company Name | Aurobindo Pharma Limited |
---|---|
Established Year | 1986 |
Headquarters | Hyderabad, India |
Official Website | Click Here |
Manufactures injectables & antibiotics, ensuring regulatory compliance & global reach.
Company Name | Cipla Limited |
---|---|
Established Year | 1935 |
Headquarters | Mumbai, India |
Official Website | Click Here |
Produces parenteral antibiotics, antivirals & life-saving injectables, focusing on affordability & patient care.